RECRUITING

The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer Treatment

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study assesses the feasibility and acceptability of a brief electronic patient-reported outcome (ePRO) tool that allows patients to self-identify impending delays. The risk of treatment delays according to tumor type and race will be measured by both ePRO and electronic health record (EHR) tools. Data from this study and the association of social determinants of health could be useful to flag patients at risk of delay and due timely intervention for modifiable treatment barriers. The prediction of the risk of treatment delay will be helpful to design another study using electronic tracking systems to prevent cancer treatment delays. The long-term goal of this research is to alert care teams when patients may be at risk of treatment days and to help patients get treatment faster. It was planned to enroll a total of 240 subjects with newly diagnosed cancer. Sixty colorectal and 180 breast cancer patients will be included.

Official Title

The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparities in Cancer Treatment Delay

Quick Facts

Study Start:2023-11-06
Study Completion:2026-05
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06096623

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Male and female patients of age \>18 years.
  2. 2. Pathologic diagnosis of breasts or colorectal cancer within 6 weeks (42 days) prior to the enrollment date.
  3. 3. Have not yet initiated cancer treatment on the date of enrollment.
  4. 4. Indicate intent to receive cancer treatment at the University of North Carolina.
  1. 1. Patient unwilling or unable to receive electronic survey links via email or text link on a mobile device, tablet, laptop, or desktop computer.
  2. 2. Patient unwilling or unable to provide verbal or signed consent to participate.
  3. 3. Patient cannot read and speak English.
  4. 4. Patients who do not have email access or a smartphone are able to receive Short Message/Messaging Service (SMS) text messages.

Contacts and Locations

Study Contact

Erin Laurie-Zehr, MA
CONTACT
919-445-6199
erin_laurie@med.unc.edu

Principal Investigator

Katie Reeder-Hayes
PRINCIPAL_INVESTIGATOR
UNC Lineberger Comprehensive Cancer Center

Study Locations (Sites)

University of North Carolina
Chapel Hill, North Carolina, 27599
United States

Collaborators and Investigators

Sponsor: UNC Lineberger Comprehensive Cancer Center

  • Katie Reeder-Hayes, PRINCIPAL_INVESTIGATOR, UNC Lineberger Comprehensive Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-11-06
Study Completion Date2026-05

Study Record Updates

Study Start Date2023-11-06
Study Completion Date2026-05

Terms related to this study

Keywords Provided by Researchers

  • patient-reported outcome
  • electronic
  • health equity
  • electronic survey
  • treatment delay

Additional Relevant MeSH Terms

  • Cancer
  • Breast Cancer
  • Colorectal Cancer